Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

Shares of drugmakers were taking a broad beating Wednesday, after President Donald Trump indicated that pharmaceuticals will no longer be excluded from tariffs. Tomi Kilgore is MarketWatch's ...

The U.S. biotech sector had already been through a brutal few years before the latest market crash. Robert F. Kennedy Jr.’s shake-up of the nation’s health agencies and persistently high ...

Potato producer Lamb Weston Holdings Inc., telecom giant Verizon Communications Inc. and retailer TJX Cos. all bucked a sharp market selloff Thursday, as Wall Street turned to stocks offering ...

Swiss pharmaceutical giant Novartis (NVS) said it plans to invest $23 billion in the construction and expansion of 10 U.S. facilities, as drugmakers brace for potential tariffs from the Trump ...

Mumbai: When the world reeled under President Trump's reciprocal tariff announcement on 3 April, the Indian pharmaceutical industry was relieved as it escaped the initial round of sweeping levies.

DUBLIN, April 10, 2025 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced that it will report its first quarter 2025 financial results on Tuesday ...

DUBLIN, April 10, 2025 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced that it will report its first quarter 2025 financial results on Tuesday, May 6, 2025 ...

Shares of major US drugmakers Amgen, AbbVie, Pfizer, Merck and Eli Lilly fell between 3 per cent and 6 per cent in premarket trading. In Europe, a basket of healthcare stocks fell 5 per cent to ...

Many of the Chinese-produced drugs are generics, which account for 91 percent of prescriptions dispensed in the U.S. Trump has been pressuring drugmakers and other industries to move manufacturing ...

Analysts believe the key question is whether India can be exempted from the pharma tariffs, given the better relationship between the countries and the critical nature of India’s generic drug ...

Pharmaceutical imports became the latest target for President Donald Trump’s tariffs, sending FTSE 100 drugmakers stock into the red. Astrazeneca plunged seven per cent and GSK 5.7 per cent.